Constructing a Benefit-Risk Analysis

Speaker

Instructor: Don Hurd
Product ID: 706571
Training Level: Intermediate

Location
  • Duration: 60 Min
ISO 14971:2019 requires an overall Benefit-Risk Analysis but many companies struggle with constructing the rationale for demonstrating overall benefits outweigh overall risks. This webinar will provide one systematic approach which has proved successful for approaching the analysis.
Purchase option for this webinar is currently unavailable. Please contact our Customer Care for more info.

 

Customer Care

Fax: +1-650-362-2367

Email: [email protected]

Read Frequently Asked Questions

Why Should You Attend:

Assessing the benefit – risk ratio is very much an inexact science. A true “weight” cannot be assigned nor can these be readily weighed against each other. Thus, many companies struggle with constructing the rationale for concluding the overall benefits outweigh the overall risks. Regulatory bodies are now taking a much closer look at the Benefit-Risk analysis and unsubstantiated claims that benefits outweigh risks are being rejected. A systematic approach to construct the rationale for such conclusions is needed.

The Benefit-Risk Analysis required by ISO 14971:2019 is a difficult concept. Neither benefits nor risks can be assigned “weight” so a systematic approach to constructing the benefit-risk analysis enables the analysis to provide the justification for claiming the overall benefits of a device outweigh the overall risks. The approach taken is aligned with guidance FDA uses when making risk-based decisions and with guidance. The approach will describe how benefits are characterized, how risks are characterized, and how these characterizations can be weighed against each other to establish a rational conclusion about the ratio.

Areas Covered in the Webinar:

  • Background (ISO 14971 requirements)
  • Participants
  • Characterizing benefits
  • Characterizing risks
  • Heat maps
  • Constructing conclusions
  • Maintaining

Free Materials to the audience related to the topic

  • Factors to Consider Regarding Benefit-Risk in Medical Device Product Availability, Compliance, and Enforcement Decisions
  • Factors to Consider When Making Benefit-Risk Determinations in Medical Device Premarket Approval and De Novo Classifications
  • MEDDEV 2.7/1 rev.4 - Clinical evaluation: Guide for manufacturers and notified bodies (ref A.7.2)
  • Sample worksheet

Who Will Benefit:

This webinar is intended for medical device professionals engaged in conducting product risk analysis. The following roles are typically involved in constructing the benefit-risk analysis:

  • Project managers
  • R&D Quality
  • Clinical personnel supporting risk management
  • Management who gives final approval for conclusions
  • Systems engineers
Instructor Profile:
Don Hurd

Don Hurd
VP Quality and Validation Services , The Realtime Group

Don Hurd has over 35 years of experience in supporting development of applications of or containing software in regulated industries, the last 17 in medical devices. With his diverse background, Mr. Hurd provides a unique insight into driving product quality and ensuring high productivity of development organizations. Mr. Hurd is currently the Vice President of Quality and Validation Services for The Realtime Group, a contract R&D firm specialized in serving the regulated industries, primarily medical devices. In this role, Mr. Hurd led the company to certification in both ISO 9001 and ISO 13485, maintaining certification for nearly 15 years. In his role at Realtime, Mr. Hurd supports clients in efforts ranging from Quality Management System development, deployment, and remediation; product and development quality planning; verification and validation of products, product software, and non-product software; supplier qualification, approval, and management; transitioning product from development to manufacturing; supporting post-market vigilance / surveillance; and interfacing with ISO auditors and FDA inspectors. Mr. Hurd has been an ASQ Certified Quality Auditor since 2009. Mr. Hurd is active in the ASQ Biomedical Division Discussion Group, ASQ Audit Special Interest Group, and bionorthTX, holding leadership positions in each.

Follow us :

 

 

Refund Policy

Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange. Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter. We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email [email protected] call +1-888-717-2436 (Toll Free).

 

 

+1-888-717-2436

6201 America Center Drive Suite 240, San Jose, CA 95002, USA

Follow Us

facebook twitter linkedin youtube

 

Copyright © 2021 ComplianceOnline.com MetricStream
Our Policies: Terms of use | Privacy

PAYMENT METHOD: 100% Secure Transaction

payment method